Targeting TAZ-driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-0332
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting the Ron-Dek Signaling Axis in Breast Cancer

2013English

The Amelioration of Renal Damage in Skp2-Deficient Mice Canceled by P27 Kip1 Deficiency in Skp2−/− P27−/− Mice

PLoS ONE
Multidisciplinary
2012English

Quinacrine Upregulates P21/P27 Independent of P53 Through Autophagy-Mediated Downregulation of P62-Skp2 Axis in Ovarian Cancer

Scientific Reports
Multidisciplinary
2018English

Targeting the CCL2-CCR2 Signaling Axis in Cancer Metastasis

Oncotarget
Oncology
2016English

Targeting HER2+ Breast Cancer: The TBK1/IKK-Epsilon Axis

Oncoscience
Cancer ResearchOncology
2014English

Skp2 Is a Promising Therapeutic Target in Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2012English

Oncogenic Role of the Ubiquitin Ligase Subunit Skp2 in Human Breast Cancer

Journal of Clinical Investigation
Medicine
2016English

Targeting Sphingosine-1-Phosphate Axis in Obesity-Promoted Breast Cancer

2016English

siRNA KNOCKDOWN SKP2 GENE IN BREAST CANCER

The Egyptian Journal of Biochemistry and Molecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy